A detailed history of Bvf Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Bvf Inc holds 1,046,000 shares of AXSM stock, worth $90.9 Million. This represents 2.99% of its overall portfolio holdings.

Number of Shares
1,046,000
Previous 955,000 9.53%
Holding current value
$90.9 Million
Previous $76.9 Million 22.25%
% of portfolio
2.99%
Previous 2.35%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$78.93 - $95.84 $7.18 Million - $8.72 Million
91,000 Added 9.53%
1,046,000 $94 Million
Q2 2024

Aug 14, 2024

BUY
$65.72 - $80.5 $62.8 Million - $76.9 Million
955,000 New
955,000 $76.9 Million
Q4 2023

Feb 14, 2024

SELL
$57.42 - $83.61 $8.61 Million - $12.5 Million
-150,000 Reduced 7.04%
1,981,100 $158 Million
Q1 2023

May 15, 2023

BUY
$58.39 - $75.0 $22 Million - $28.2 Million
376,100 Added 21.43%
2,131,100 $131 Million
Q4 2022

Feb 14, 2023

BUY
$39.94 - $79.72 $70.1 Million - $140 Million
1,755,000 New
1,755,000 $135 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.73B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.